BTAIVSVBIO• 12 Months (Normalized)
BTAI vs VBIO (BioXcel Therapeutics Inc. vs Valion Bio Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-98.58%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VBIO Performance $2.1
-97.24%
Valion Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin VBIO LEADS
-1.34%
VBIO outperforming by 1.34%
BTAIVBIO
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BTAI Price | BTAI Gain (%) | VBIO Price | VBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $0.05 | -98.58% | $2.10 | -97.24% | -1.34% |
| Sep 11, 2026 | $0.05 | -98.39% | $2.26 | -97.03% | -1.36% |
| Sep 10, 2026 | $0.05 | -98.42% | $2.20 | -97.11% | -1.31% |
| Sep 09, 2026 | $0.05 | -98.52% | $2.40 | -96.84% | -1.68% |
| Sep 08, 2026 | $0.04 | -98.64% | $2.50 | -96.71% | -1.93% |
| Sep 04, 2026 | $0.07 | -97.67% | $2.77 | -96.36% | -1.31% |
| Sep 03, 2026 | $0.12 | -96.28% | $2.80 | -96.32% | +0.04% |
| Sep 02, 2026 | $0.11 | -96.62% | $3.12 | -95.89% | -0.73% |
| Sep 01, 2026 | $0.14 | -95.68% | $3.07 | -95.96% | +0.28% |
| Aug 31, 2026 | $0.16 | -94.86% | $3.57 | -95.30% | +0.44% |
| Aug 28, 2026 | $0.18 | -94.29% | $3.03 | -96.02% | +1.73% |
| Aug 27, 2026 | $0.72 | -77.32% | $3.08 | -95.95% | +18.63% |
| Aug 26, 2026 | $0.78 | -75.39% | $3.90 | -94.87% | +19.48% |
| Aug 25, 2026 | $0.74 | -76.59% | $3.98 | -94.77% | +18.18% |
| Aug 24, 2026 | $0.76 | -75.99% | $4.15 | -94.54% | +18.55% |
Page 1 of 17